IMU 2.56% 3.8¢ imugene limited

Ann: Imugene doses first patient in HER-Vaxx phase 2 trial

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 851
    • Release Date: 14/03/19 09:06
    • Summary: Imugene doses first patient in HER-Vaxx phase 2 trial
    • Price Sensitive: Yes
    • Download Document    Not available as of the moment.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $386.7M
Open High Low Value Volume
3.8¢ 3.9¢ 3.8¢ $134.8K 3.498M

Buyers (Bids)

No. Vol. Price($)
23 1738258 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 494405 4
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.